Ultragenyx Pharmaceutical Logo

Ultragenyx Pharmaceutical

🇺🇸
RARE
US90400D1081

Ultragenyx Pharmaceutical is a US-based biopharmaceutical company dedicated to the development and commercialization of transformative medicines for rare and ultra-rare genetic diseases. The company focuses on innovative therapeutic approaches, including gene therapies and other novel biologics, to offer patients worldwide new treatment options and improved quality of life.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
After-Hours
In 25 days

Stock Price

All Dates

Company Information

Name
Ultragenyx Pharmaceutical
Ticker Symbol
RARE
ISIN
US90400D1081
Country
🇺🇸
USA